...
首页> 外文期刊>Macedonian Academy of Sciences and Arts: Section of Biological and Medical Sciences >FEMOROPOPLITEAL BYPASS VS PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY AND STENTING IN TREATMENT OF PERIPHERAL ARTERY DISEASES OF INFRAINQUINAL SEGMENT – SHORT-TERM RESULTS
【24h】

FEMOROPOPLITEAL BYPASS VS PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY AND STENTING IN TREATMENT OF PERIPHERAL ARTERY DISEASES OF INFRAINQUINAL SEGMENT – SHORT-TERM RESULTS

机译:股骨ITE旁结扎术与经皮腔内血管成形术和狭窄治疗小腿股沟周围小动脉疾病-短期结果

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Critical limb ischaemia is a result of occlusive arterial disease in the infrainquinal segment and is a major indication for arterial revascularization, which implies a femoropopliteal bypass procedure or an interventional procedure ¨C stent graf-ting of the occluded segment. Although indications for both techniques are clearly defined, there are still controversies. Thus, the aim of this study was to determine short-term results in patients treated with these two treatment modalities. In the period between 2002 and 2008 a total of 70 patients with occlusive arte-rial diseases of the low extremity were analysed. In 50 out of 70 patients a femoro-popliteal bypass was made. Of these, in 30 (60%) patients PTFE material was used and in 20 (40%) patients an autologous saphenous vein graft was used. The other group comprised 20 patients who underwent stenting. In patients treated with surgical revas-cularization, the major indication for surgery was occlusive arterial disease in: stage II ¨C in 10 patients (20%), stage III ¨C in 5 patients (10%), stage IV ¨C in 25 patients (50%) and the remaining 10 patients (20%) had subacute ischaemia. Arteriography showed three crural patent tributaries in 18% of the patients, two patent crural tributaries in 40% of the patients and one crural patent tributary in 32% of the patients. There were no significant differences concerning indications and arteriographic findings between the two subgroups. The follow-up period lasted for 6 months and the patency rate was 85% (17) for venous bypass, 11 (64.6%) ¨C short-segment lesions ( 4 cm) versus 76.5% (23) for PTFE graft (p 4 cm).The following results were obtained for the second group of patients: initially successful stents in 85%; failure in 15% or 2 patients; technical failure in 1 patient or 5%. After 6 months the patency rate was 75% (15), of which 11 patients (73.2%) had short-segment occlusions ( 4 cm. The baseline value of the lower limb index (ABI ¨C ankle-brachial index) was significantly increased in both groups, from 0.41 to 0.91 in the group with surgical revascularization and from 0.47 to 0.88 in the second group treated with stenting. The same trend was observed after six months. This study demonstrated a small but significant difference (85% vs 75%, p 0.05 p = ns). It is obvious that the results are identical to those in treatment with an autologous great saphenous vein, but in comparison with PTFE the results imply stent usage (73.2% vs 56.5%, p < 0.005). Prosthesis (PTFE) is a graft material of choice when the great saphenous vein is used, damaged or calcified and when the occlusion is longer than 4 cm and is not suitable for stent grafting (43.5% vs 26.6%, p < 0.001).
机译:严重肢体缺血是下颌节段闭塞性动脉疾病的结果,并且是动脉血运重建的主要指征,这意味着股lite旁路手术或介入程序-闭塞节段的支架移植。尽管两种技术的适应症都有明确的定义,但仍然存在争议。因此,本研究的目的是确定接受这两种治疗方式治疗的患者的短期结果。在2002年至2008年期间,共分析了70例下肢阻塞性动脉疾病患者。 70名患者中有50名进行了股-旁路术。其中,在30名(60%)患者中使用了PTFE材料,在20名(40%)患者中使用了自体的大隐静脉移植物。另一组包括20例接受支架置入术的患者。在接受手术治疗的患者中,手术的主要指征是闭塞性动脉疾病:II期– 10例(20%),III期– 5例(10%),IV期25例患者(50%),其余10位患者(20%)患有亚急性缺血。动脉造影显示18%的患者有3个主要专利支流,40%的患者有2个主要专利支流,32%的患者有1个主要专利支流。两个亚组之间在适应症和动脉造影发现方面无显着差异。随访期为6个月,静脉搭桥术的通畅率为85%(17),短节段性病变(4 cm)为11(64.6%)-PTFE移植为76.5%(23)(p 4对于第二组患者,获得了以下结果:最初成功使用支架的患者占85%。 15%或2例患者失败; 1名患者出现技术故障或5%。 6个月后,通畅率为75%(15),其中11例(73.2%)发生了短节闭塞(4厘米)。下肢指数(ABI-C踝臂指数)的基线值显着增加在两组中,手术血运重建组分别为0.41至0.91,第二组接受支架置入术的比例为0.47至0.88。六个月后观察到了相同的趋势。该研究表明差异很小但差异显着(85%vs 75% ,p 0.05 p = ns)。显然,该结果与自体大隐静脉治疗的结果相同,但与PTFE相比,该结果暗示了支架的使用(73.2%vs 56.5%,p <0.005)。当使用大隐静脉,损伤或钙化并且闭塞时间长于4 cm并且不适合进行支架移植时,(PTFE)是首选的移植材料(43.5%vs 26.6%,p <0.001)。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号